SERA PROGNOSTICS, INC. (SERA) · INSIDERData sourcesSEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago
Public companySERA PROGNOSTICS, INC.
SERACIK 0001534969
Price$2.19
1 year-29.1%
Disclosed transactions15
Buys / sells0 / 12
Max Insider Score40
Connections with evidence9
SERA · disclosed activity on price
| Score | Actor | Security | Side | Value | Executed | Disclosed | Lag | Source | Evidence |
|---|
| 21 | IDInglis Tiffany Eul DavisChief Medical Officer | SERASERA PROGNOSTICS, INC. Open-market sale | SELL | $16K 8,024 sh | Oct 12, 2026 |
| Oct 13, 2026 traded Oct 12, 2026 |
| 36 | JBJackson BenjaminGeneral Counsel | SERASERA PROGNOSTICS, INC. Open-market sale | SELL | $4,380 2,190 sh | Sep 10, 2026 | Sep 11, 2026 traded Sep 10, 2026 | +1d | SEC Form 4 | |
| 32 | ALAnderson Dyaarl Lee Jr.Chief Commercial Officer | SERASERA PROGNOSTICS, INC. Open-market sale | SELL | $3,600 1,800 sh | Sep 10, 2026 | Sep 11, 2026 traded Sep 10, 2026 | +1d | SEC Form 4 | |
| 32 | LZLindgardt ZhenyaDirector, Chief Executive Officer | SERASERA PROGNOSTICS, INC. Open-market sale | SELL | $14K 7,022 sh | Sep 10, 2026 | Sep 11, 2026 traded Sep 10, 2026 | +1d | SEC Form 4 | |
| 32 | IDInglis Tiffany Eul DavisChief Medical Officer | SERASERA PROGNOSTICS, INC. Open-market sale | SELL | $972 486 sh | Sep 10, 2026 | Sep 11, 2026 traded Sep 10, 2026 | +1d | SEC Form 4 | |
| 32 | LZLindgardt ZhenyaDirector, Chief Executive Officer | SERASERA PROGNOSTICS, INC. Open-market sale | SELL | $40K 20.1K sh | Sep 8, 2026 | Sep 9, 2026 traded Sep 8, 2026 | +1d | SEC Form 4 | |
| 9 | GSGleason ScottChief Financial Officer | SERASERA PROGNOSTICS, INC. Grant or award | A | — 169.6K sh | Aug 31, 2026 | Sep 1, 2026 traded Aug 31, 2026 | +1d | SEC Form 4 | |
| 9 | GSGleason ScottChief Financial Officer | SERASERA PROGNOSTICS, INC. Grant or award | A | — 117.9K sh | Aug 31, 2026 | Sep 1, 2026 traded Aug 31, 2026 | +1d | SEC Form 4 | |
| 32 | LZLindgardt ZhenyaDirector, Chief Executive Officer | SERASERA PROGNOSTICS, INC. Open-market sale | SELL | $14K 6,990 sh | Jun 11, 2026 | Jun 15, 2026 traded Jun 11, 2026 | +4d | SEC Form 4 | |
| 32 | AAAerts AustinChief Financial Officer | SERASERA PROGNOSTICS, INC. Open-market sale | SELL | $4,094 2,037 sh | Jun 11, 2026 | Jun 15, 2026 traded Jun 11, 2026 | +4d | SEC Form 4 | |
| 40 | ALAnderson Dyaarl Lee Jr.Chief Commercial Officer | SERASERA PROGNOSTICS, INC. Open-market sale | SELL | $9,525 4,739 sh | Jun 11, 2026 | Jun 15, 2026 traded Jun 11, 2026 | +4d | SEC Form 4 | |
| 36 | IDInglis Tiffany Eul DavisChief Medical Officer | SERASERA PROGNOSTICS, INC. Open-market sale | SELL | $728 362 sh | Jun 11, 2026 | Jun 15, 2026 traded Jun 11, 2026 | +4d | SEC Form 4 | |
| 36 | AAAerts AustinChief Financial Officer | SERASERA PROGNOSTICS, INC. Open-market sale | SELL | $11K 5,440 sh | Jun 9, 2026 | Jun 10, 2026 traded Jun 9, 2026 | +1d | SEC Form 4 | |
| 36 | LZLindgardt ZhenyaDirector, Chief Executive Officer | SERASERA PROGNOSTICS, INC. Open-market sale | SELL | $43K 20.8K sh | Jun 9, 2026 | Jun 10, 2026 traded Jun 9, 2026 | +1d | SEC Form 4 | |
| 9 | ALAnderson Dyaarl Lee Jr.Chief Commercial Officer | SERASERA PROGNOSTICS, INC. Grant or award | A | $5,829 3,168 sh | May 29, 2026 | Jun 1, 2026 traded May 29, 2026 | +3d | SEC Form 4 | |
Director, Chief Executive Officer · Jun 10, 2026